Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Guzman

Showing results (171-180 of 213) with videos related to

Pageof 22
Sort By:
RSC Advances|July 23, 2024
Synthesis of novel fatty acid 3,4-dihydropyrimidin-2-(1<i>H</i>)-one and antitumoral activity against breast and gastric cancer cellsE A M Rios, C M Dea, E R F B Dos Santos, et al.
JCO Precision Oncology|January 13, 2022
Mutant <i>PPM1D</i>- and <i>TP53</i>-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide TherapyAbhay Singh, Nuria Mencia-Trinchant, Elizabeth A Griffiths, et al.
Haematologica|September 11, 2025
Wild-type p53 overexpression in <i>NPM1</i>-mutated acute myeloid leukemia: potential implications for disease biology and therapy responsePaul D Barone, Siarhei Dzedzik, Ashley S Kleinman, et al.
Frontiers in Immunology|January 24, 2017
Pro-inflammatory-Related Loss of CXCL12 Niche Promotes Acute Lymphoblastic Leukemic Progression at the Expense of Normal LymphopoiesisJuan Carlos Balandrán, Jessica Purizaca, Jennifer Enciso, et al.
Leukemia Research|August 13, 2022
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insightsNaveen Pemmaraju, Nathaniel R Wilson, Jayastu Senapati, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 20, 2015
Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cellsLina Han, Peng Qiu, Zhihong Zeng, et al.
Blood Advances|November 8, 2019
Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cellsLaura M Bystrom, Daniel P Bezerra, Hsiao-Ting Hsu, et al.
Nature Medicine|July 25, 2018
Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemiaNikos Kourtis, Charalampos Lazaris, Kathryn Hockemeyer, et al.
Frontiers in Oncology|September 16, 2021
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AMLAmanda Lopez, Sanjay Patel, Julia T Geyer, et al.
RSC Advances|March 18, 2026
Synthesis and <i>in vitro</i> antitumor evaluation of novel 3,4-dihydropyrimidinone-vorinostat hybrids against gastric and breast cancer cell linesE A M Rios, G M S D M Pereira, M G M D'Oca, et al.
Pageof 22

Showing results (171-180 of 213) with videos related to

Sort By:
Pageof 22
RSC Advances|July 23, 2024
Synthesis of novel fatty acid 3,4-dihydropyrimidin-2-(1<i>H</i>)-one and antitumoral activity against breast and gastric cancer cellsE A M Rios, C M Dea, E R F B Dos Santos, et al.
JCO Precision Oncology|January 13, 2022
Mutant <i>PPM1D</i>- and <i>TP53</i>-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide TherapyAbhay Singh, Nuria Mencia-Trinchant, Elizabeth A Griffiths, et al.
Haematologica|September 11, 2025
Wild-type p53 overexpression in <i>NPM1</i>-mutated acute myeloid leukemia: potential implications for disease biology and therapy responsePaul D Barone, Siarhei Dzedzik, Ashley S Kleinman, et al.
Frontiers in Immunology|January 24, 2017
Pro-inflammatory-Related Loss of CXCL12 Niche Promotes Acute Lymphoblastic Leukemic Progression at the Expense of Normal LymphopoiesisJuan Carlos Balandrán, Jessica Purizaca, Jennifer Enciso, et al.
Leukemia Research|August 13, 2022
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insightsNaveen Pemmaraju, Nathaniel R Wilson, Jayastu Senapati, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 20, 2015
Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cellsLina Han, Peng Qiu, Zhihong Zeng, et al.
Blood Advances|November 8, 2019
Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cellsLaura M Bystrom, Daniel P Bezerra, Hsiao-Ting Hsu, et al.
Nature Medicine|July 25, 2018
Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemiaNikos Kourtis, Charalampos Lazaris, Kathryn Hockemeyer, et al.
Frontiers in Oncology|September 16, 2021
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AMLAmanda Lopez, Sanjay Patel, Julia T Geyer, et al.
RSC Advances|March 18, 2026
Synthesis and <i>in vitro</i> antitumor evaluation of novel 3,4-dihydropyrimidinone-vorinostat hybrids against gastric and breast cancer cell linesE A M Rios, G M S D M Pereira, M G M D'Oca, et al.
Pageof 22